Ethyl 7-methylimidazo[1,2-a]pyridine-3-carboxylate

Catalog No.: 
ACFDNI697
CAS No.: 
1397228-36-2
Molecular Formula: 
C11H12N2O2
Molecular Weight: 
204.23
Ethyl 7-methylimidazo[1,2-a]pyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$69.00In stockInquiry
5g97%$338.00In stockInquiry
25g97%$1656.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 7-methylimidazo[1,2-a]pyridine-3-carboxylate
IUPAC Nameethyl 7-methylimidazo[1,2-a]pyridine-3-carboxylate
MDL No.MFCD19703270
Molecular FormulaC11H12N2O2
Molecular Weight204.23
SMILESO=C(C1=CN=C2C=C(C)C=CN21)OCC
InChI KeyORBLAPOUYKOLSA-UHFFFAOYSA-N
Synonym7-Methylimidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester;Imidazo[1,2-a]pyridine-3-carboxylic acid, 7-methyl-, ethyl ester
CAS No.1397228-36-2

Synthetic Route by SureRoute

1. ACFDNI697 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACKJMS923 route compound structure diagram
    ACKJMS92321801-80-9In Stock
  4. Then
  5. ACFDNI697 route product structure diagram
    ACFDNI6971397228-36-2In Stock
Inquiry

2. ACFDNI697 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. ACMPEH694 route compound structure diagram
    ACMPEH6941134327-98-2In Stock
  4. Then
  5. ACFDNI697 route product structure diagram
    ACFDNI6971397228-36-2In Stock
Inquiry

3. ACFDNI697 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. ACCGIY532 route compound structure diagram
    ACCGIY5321296201-68-7In Stock
  4. Then
  5. ACFDNI697 route product structure diagram
    ACFDNI6971397228-36-2In Stock
Inquiry

Comments (0)